BSX vs COLD · P/E 20, rev $16.75B vs rev $2.67B
Boston Scientific Corp (BSX) versus Americold Realty Trust (COLD) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Americold Realty Trust (COLD) is a reit - industrial company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported COLD revenue for 2024-12-31 was $2.67B. Net income was -$94.7M. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. COLD currently screens at market cap $4.75B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. COLD currently screens at market cap $4.75B.
Not investment advice. Open the BSX and COLD stock pages for the full models.
Not investment advice.